The developed markets of North America and Europe together saw approximately 81% of the Phase I trial share in 2013 which is a 6% increase from 2012. Trials
Mathini Ilancheran
Advertisement
Mathini Ilancheran is a Senior Research Analyst, with Beroe Inc, Chennai, India
Articles by Mathini Ilancheran
Advertisement
Latest Updated Articles
Is South Korea the Next Emerging Early Phase Destination?Published: January 29th 2015 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
3
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
4
Establishing Governance for No-Code AI in Clinical Operations
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
